Emcure Pharmaceuticals Share Price Today | Stock Price & Emcure Pharmaceuticals Share Screener

Track the current stock price of Emcure Pharmaceuticals with an interactive chart. Analyse EMCURE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Emcure Pharmaceuticals stock quote in one place.

The quote of ₹1,937.10 sits between the 52-week low of ₹1,318.90 and the 52-week high of ₹2,009.60, and the latest session moved -0.39% from the previous close.

Screen Emcure Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EMCURE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with SATISH RAMANLAL MEHTA listed as chairperson or CEO, and it trades under ISIN INE168P01015.

Emcure Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1981. It develops, manufactures, and globally markets pharmaceutical products across various therapeutic areas. The company operates 13 manufacturing facilities in India and has a presence in over 70 countries, with a strong focus on India, Europe, and Canada. Emcure specializes...more

Classification

Identifiers and Leadership

Screen EMCURE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹9,613, up from ₹8,233 in 2025.

Latest statistics put total assets at ₹9,613 and shareholder funds at ₹4,977, with a leverage ratio of 0.27.

Screen Emcure Pharmaceuticals income statement and profit fundamentals. Analyze EMCURE quarterly results. Emcure Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹2,583 and net profit was ₹293, equal to earnings per unit of ₹15.50, at an operating margin of 21%.

In that period expenses were ₹2,048, interest cost ₹32 and tax ₹101. The next period listed, 2026-Mar, shows revenue of ₹2,484 and net profit of ₹244.

Screen EMCURE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹944, and net cash flow was an inflow of ₹112.

Over the same period, investing activities used ₹1,175 and financing activities provided ₹343.

See Emcure Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Emcure Pharmaceuticals promoter holding and ownership changes for EMCURE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 77.87%, foreign institutions 3.35%, domestic institutions 6.10% and the public 6.46%, spread across 122,189 shareholders.

The shareholder count was 122,189 in 2026-Mar, compared with 124,991 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Emcure Pharmaceuticals. Emcure Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.60 per unit for 2026-March, a yield of 0.19%, compared with ₹3.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.60, ₹3.00 and ₹2.00 per unit.

See which indices include Emcure Pharmaceuticals stock. Check EMCURE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 10 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX MIDCAP, NIFTY 500.

Get Emcure Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Emcure Pharmaceuticals stock events that may affect EMCURE share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 21, 2026, with a record date of September 21, 2026.

It is followed by Dividend dated September 4, 2026 and Quarterly Result Announcement dated August 6, 2026.

Screen EMCURE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen EMCURE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 1, 2026 and September 29, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 9 balance sheet periods, 13 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.